In vitro neurosphere formation correlates with poor survival in glioma

IUBMB Life. 2019 Feb;71(2):244-253. doi: 10.1002/iub.1964. Epub 2018 Nov 4.

Abstract

Sphere formation is an indicator of tumor aggressiveness independent of the tumor grade; however, its relation to progression-free survival (PFS) is less known. This study was designed to assess the neurosphere forming ability among low grade glioma (LGG) and high-grade glioma (HGG), its stem cell marker expression, and correlation to PFS. Tumor samples of 140 patients, including (LGG; n = 67) and (HGG; n = 73) were analyzed. We used sphere forming assay, immunofluorescence, and immunohistochemistry to characterize the tumors. Our study shows that, irrespective of the pathological sub type, both LGG and HGG formed neurospheres in vitro under conventional sphere forming conditions. However, the number of neurospheres formed from tumor tissues were significantly higher in HGG compared to LGG (P < 0.0001). Different grades of glioma were further characterized for the expression of stem cell marker proteins and lineage markers. When neurospheres were analyzed, CD133 positive cells were identified in addition to CD15 and nestin positive cells in both LGG and HGG. When these neurospheres were subjected to differentiation, cells positive for GFAP and β-tubulin III were observed. Expression of stem cell markers and β-tubulin III were prominent in HGG compared to LGG, whereas GFAP expression was higher in LGG than in HGG. Kaplan-Meier survival analysis demonstrated that neurosphere forming ability was significantly associated with shorter PFS (P < 0.05) in both LGG and HGG. Our results supports earlier studies that neurosphere formation may serve as a definitive indicator of stem cell population within the tumor and thus a better predictor of PFS than the tumor grades alone. © 2018 IUBMB Life, 71(1):244-253, 2019.

Keywords: CD133; CD15; glioma; gliomasphere; neurosphere; survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen / genetics
  • AC133 Antigen / metabolism
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / genetics
  • Brain Neoplasms / mortality
  • Brain Neoplasms / pathology
  • Cell Differentiation
  • Child
  • Child, Preschool
  • Female
  • Gene Expression
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / metabolism
  • Glioma / diagnosis*
  • Glioma / genetics
  • Glioma / mortality
  • Glioma / pathology
  • Humans
  • Infant
  • Lewis X Antigen / genetics
  • Lewis X Antigen / metabolism
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplastic Stem Cells / metabolism*
  • Neoplastic Stem Cells / pathology
  • Nestin / genetics
  • Nestin / metabolism
  • Neurons / metabolism*
  • Neurons / pathology
  • Prognosis
  • Spheroids, Cellular / metabolism*
  • Spheroids, Cellular / pathology
  • Survival Analysis
  • Tubulin / genetics
  • Tubulin / metabolism

Substances

  • AC133 Antigen
  • Biomarkers, Tumor
  • GFAP protein, human
  • Glial Fibrillary Acidic Protein
  • Lewis X Antigen
  • NES protein, human
  • Nestin
  • PROM1 protein, human
  • Tubulin